2022-06-02T09:01:36-04:00 2021-12-31 461517562 Simmons & Jamieson CPAs 6525 The Corners Parkway Peachtree Corners GA 30092 990 2021-01-01 760700153 AMERICAN PARTNERSHIP FOR EOSINOPHILIC DISORDERS AMER PO BOX 29545 ATLANTA GA 30359 WENDY M BOOK MD PRESIDENT 7134937749 2022-05-25 true WENDY BOOK James B Murphy P00847588 7704482525 2022-06-02 0 00 AAL1 IAL1 2021 2022-09-23 18:48:47Z APFED 643088 false X APFED.ORG X 2001 TX SEE SCHEDULE O 11 11 4 15 0 0 267921 419543 224000 222500 55 82 59216 623 551192 642748 88010 50000 0 141550 148335 0 23790 140586 215861 370146 414196 181046 228552 419596 651819 3497 7168 416099 644651 SEE SCHEDULE O 290123 EDUCATION, AWARENESS, ADVOCACY, AND SUPPORT: APFED HOSTED ITS ANNUAL PATIENT CONFERENCE VIRTUALLY. WE CELEBRATED NATIONAL EOSINOPHIL AWARENESS WEEK BY DISSEMINATING RESOURCES, AND ENGAGING PATIENTS AND STAKEHOLDERS. APFED PRODUCES MONTHLY EDUCATIONAL E-NEWS AND A QUARTERLY NEWSLETTER TO PATIENTS AND CAREGIVERS AND DEVELOPED AN ONLINE TOOLKIT IN PARTNERSHIP WITH THE ALLERGY & ASTHMA NETWORK TO HELP PATIENTS MANAGE EOSINOPHILIC ASTHMA. APFED LAUNCHED A NEW PODCAST SERIES AND A WEBINAR SERIES TO PROVIDE A VIRTUAL FORUM FOR PATIENTS TO LEARN ABOUT A VARIETY OF TOPICS RELEVANT TO PATIENTS. WE MET WITH MEMBERS OF THE U.S. CONGRESS TO EDUCATE THEM ABOUT NEEDS OF PATIENTS AND NEED FOR ACCESS TO THERAPIES. ADVOCATED AND SUPPORTED GRASSROOT EFFORTS RESULTING IN PASSAGE OF THE FASTER ACT, REQUIRING COMMERCIAL INGREDIENT LABELING AND TO INCREASE PRIORITY OF FEDERALLY FUNDED FOOD ALLERGY RESEARCH. PARTICIPATED IN INVITATIONAL COLLABORATIVES WITH GLOBAL THOUGHT LEADERS TO ADVANCE PATIENT CARE 71854 RESEARCH:APFED AWARDED TWO $50,000 2-YEAR RESEARCH PILOT GRANTS THROUGH OUR HOPE ON THE HORIZON RESEARCH GRANT PROGRAM, TWO ABSTRACT AWARDS IN TANDEM WITH THE 2021 ANNUAL MEETING OF THE NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION, AND CO-AUTHORED TWO RESEARCH STUDIES TO SHED LIGHT ON PERCEPTIONS OF COVID 19 AMONG THE EOE POPULATION. APFED ATTENDED THE VIRTUAL MEETING OF THE AAAAI AND DISSEMINATED RESOURCES TO HEALTHCARE PROVIDERS. WE DISSEMINATED INFORMATION ABOUT RESEARCH OPPORTUNITIES FOR PATIENTS, COLLABORATED WITH CEGIR. APFED MAINTAINED PARTNERSHIP FOR THE EOSINOPHIL.CONNECT PATIENT INSIGHTS NETWORK AND CONTINUED ON STEERING COMMITTEE FOR THE EGID PARTNERS REGISTRY. APFED SPONSORED THE IES 2021 SCIENCE SERIES VIRTUAL SEMINARS FOR THE MEDICAL COMMUNITY AND ENDORSED THE 2021 JAMES W. FRESTON SINGLE TOPIC CONFERENCE THAT BROUGHT TOGETHER PROVIDERS, RESEARCHERS, AND PATIENT ADVOCACY GROUPS TO EXAMINE AND DISCUSS EOSINOPHILS IN GI DESEASE. 361977 true true false false false false false false false false false false false false false false true false false false false false false false true false false true false false false false false false false false false false false false false false false false false false false true 0 0 4 true false false false false false false false false X 11 11 true false false false true false false true true false false true true true false true true false false false AK AL AR CA CO CT FL GA HI KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X X MICHAEL PIANSKY MD 7134937749 PO BOX 29545 ATLANTA GA 30359 MARY JO STROBEL EXECUTIVE DIRECTOR 50.00 0.00 X 83902 0 0 DAWN MCCOY DIRECTOR 15.00 0.00 X 0 0 0 KATHLEEN SABLE DIRECTOR 20.00 0.00 X 0 0 0 JULIET ROSS DIRECTOR 10.00 0.00 X 0 0 0 DONALYN DENISE MACK DIRECTOR 15.00 0.00 X 0 0 0 GERALD J GLEICH MEDICAL ADVISOR 5.00 0.00 X 0 0 0 TOM FANNING WEB COORDINATOR 15.00 0.00 X 0 0 0 ELIZABETH MCCARTY VICE PRESIDENT 5.00 0.00 X X 0 0 0 WENDY M BOOK PRESIDENT 15.00 0.00 X X 0 0 0 MICHAEL PIANSKY TREASURER 15.00 0.00 X X 0 0 0 PRADYUMNA TUMMALA CHAIRMAN 5.00 0.00 X X 0 0 0 GILES M SCHANEN SECRETARY 10.00 0.00 X X 0 0 0 83902 0 0 0 false false false 4370 29227 385946 419543 PATIENT EDUCATION PARTN 611710 222500 222500 222500 82 82 29227 963 340 623 623 642748 223205 0 0 50000 50000 83902 82224 1678 53915 37514 154 16247 10518 9135 140 1243 11160 11160 2024 2024 6214 6214 111603 111603 3447 3447 STATE REGISTRATION 6093 6093 EDUCATION PROGRAMS 71501 71501 BANK CHARGES and Merchant Ac 3612 3612 OTHER 207 207 414196 361977 28429 23790 419596 651819 419596 651819 3497 7168 3497 7168 X 416099 644651 416099 644651 419596 651819 228552 0 X false true X true X 541044 407444 322439 329612 385968 1986507 105700 101270 174538 225216 256075 862799 2112 3192 4059 978 963 11304 648856 511906 501036 555806 643006 2860610 2860610 299 155 121 55 82 712 299 155 121 55 82 712 649155 512061 501157 555861 643088 2861322 0.99980 0.99960 0.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true false false false false false false false false false 643088 643088 -340 -340 642748 414536 414536 -340 -340 414196 Other revenues included on Form 990 (Part XI, line 4b) COST OF GOOD SOLD $340. Other expenses included on Form 990 (Part XII, line 4b) COST OF GOOD SOLD $340. Other 3467 3467 HOPE-HORIZON 17130 17130 207 20597 20597 207 207 20390 false THE REGENTS OF THE UNIVERSITY OF CA 9500 GILMAN DRTIVE MC 0009 LA JOLLA CA 920930009 25000 RESEARCH MAYO CLINIC ARIZONA PO BOX 860334 MINNEAPOLIS MN 554860334 25000 RESEARCH 2 Officer directors etc family relationship Part VI line 2 Wendy M Book, MD - PresidentMichael Piansky, MD - TreasurerRelated by marriage Members or stockholder classes and rights Part VI line 6 The organization has members and memberships that are open to anyone who wishes to be involved in the cause. Form 990 governing body review Part VI line 11 The organizations tax return preparer provided a preliminary copy of the return to board members for review. Any necessary changes are made and the final return is presented to the president for signature and filing. Governing documents etc available to public Part VI line 19 The organization makes its governing documents, conflicts of interest statement and financial statements available to the pubic upon written request. General explanation attachment Form 990, Part III, Item 1 Organizations MissionEDUCATION, AWARENESS, ADVOCACY AND SUPPORT:APFED HOSTED ITS ANNUAL PATIENT CONFERENCE VIRTUALLY. WE CELEBRATED NATIONAL EOSINOPHIL AWARENESS WEEK BY DISSEMINATING RESOURCES, AND ENGAGING PATIENTS AND STAKEHOLDERS. APFED PRODUCES MONTHLY EDUCATIONAL E-NEWS AND A QUARTERLY NEWSLETTER TO PATIENTS AND CAREGIVERS AND DEVELOPED AN ONLINE TOOLKIT IN PARTNERSHIP WITH THE ALLERGY & ASTHMA NETWORK TO HELP PATIENTS MANAGE EOSINOPHILIC ASTHMA. APFED LAUNCHED A NEW PODCAST SERIES AND A WEBINAR SERIES TO PROVIDE A VIRTUAL FORUM FOR PATIENTS TO LEARN ABOUT A VARIETY OF TOPICS RELEVANT TO PATIENTS. WE MET WITH MEMBERS OF THE U.S. CONGRESS TO EDUCATE THEM ABOUT NEEDS OF PATIENTS AND NEED FOR ACCESS TO THERAPIES. ADVOCATED AND SUPPORTED GRASSROOT EFF Form 990, Part I, Item 1 Organizations Mission or Most Significant ActivitiesEDUCATION, AWARENESS, ADVOCACY AND SUPPORT:APFED HOSTED ITS ANNUAL PATIENT CONFERENCE VIRTUALLY. WE CELEBRATED NATIONAL EOSINOPHIL AWARENESS WEEK BY DISSEMINATING RESOURCES, AND ENGAGING PATIENTS AND STAKEHOLDERS. APFED PRODUCES MONTHLY EDUCATIONAL E-NEWS AND A QUARTERLY NEWSLETTER TO PATIENTS AND CAREGIVERS AND DEVELOPED AN ONLINE TOOLKIT IN PARTNERSHIP WITH THE ALLERGY & ASTHMA NETWORK TO HELP PATIENTS MANAGE EOSINOPHILIC ASTHMA. APFED LAUNCHED A NEW PODCAST SERIES AND A WEBINAR SERIES TO PROVIDE A VIRTUAL FORUM FOR PATIENTS TO LEARN ABOUT A VARIETY OF TOPICS RELEVANT TO PATIENTS. WE MET WITH MEMBERS OF THE U.S. CONGRESS TO EDUCATE THEM ABOUT NEEDS OF PATIENTS AND NEED FOR ACCESS TO THERAPIES. ADVOCATED AND SUPPORTED GRASSROOT EFFORTS RESULTING IN PASSAGE OF THE FASTER ACT, REQUIRING COMMERCIAL INGREDIENT LABELING AND TO INCREASE PRIORITY OF FEDERALLY FUNDED FOOD ALLERGY RESEARCH. PARTICIPATED IN INVITATIONAL COLLABORATIVES WITH GLOBAL THOUGHT LEADERS TO ADVANCE PATIENT CARE. RESEARCH: APFED AWARDED TWO $50,000 2-YEAR RESEARCH PILOT GRANTS THROUGH OUR HOPE ON THE HORIZON RESEARCH GRANT PROGRAM, TWO ABSTRACT AWARDS IN TANDEM WITH THE 2021 ANNUAL MEETING OF THE NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION, AND CO-AUTHORED TWO RESEARCH STUDIES TO SHED LIGHT ON PERCEPTIONS OF COVID 19 AMONG THE EOE POPULATION. APFED ATTENDED THE VIRTUAL MEETING OF THE AAAAI AND DISSEMINATED RESOURCES TO HEALTHCARE PROVIDERS. WE DISSEMINATED INFORMATION ABOUT RESEARCH OPPORTUNITIES FOR PATIENTS, COLLABORATED WITH CEGIR. APFED MAINTAINED PARTNERSHIP FOR THE EOSINOPHIL.CONNECT PATIENT INSIGHTS NETWORK AND CONTINUED ON STEERING COMMITTEE FOR THE EGID PARTNERS REGISTRY. APFED SPONSORED THE IES 2021 SCIENCE SERIES VIRTUAL SEMINARS FOR THE MEDICAL COMMUNITY AND ENDORSED THE 2021 JAMES W. FRESTON SINGLE TOPIC CONFERENCE THAT BROUGHT TOGETHER PROVIDERS, RESEARCHERS, AND PATIENT ADVOCACY GROUPS TO EXAMINE AND DISCUSS EOSINOPHILS IN GI DISEASE.